Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1The Motley Fool • 07/18/26
The First Oral Cholesterol Pill Is Here. Which of These 5 Stocks Benefits Most?24/7 Wall Street • 07/17/26
Novo Nordisk (NVO) Ascends While Market Falls: Some Facts to NoteZacks Investment Research • 07/16/26
Medicare's $50 Weight-Loss Drug Window Opens In July: What Smart Enrollees Do Before 2027Benzinga • 07/16/26
The Next Wave Of Peptides Could Be Here; What Does It Mean For Lilly, Novo?Investors Business Daily • 07/16/26
Wegovy Pill in Europe - Novo Nordisk Expands Franchise With First European Approval for Oral Weight Loss DrugBenzinga • 07/15/26
It's been three months since Lilly launched its obesity pill. Most people are taking Novo's pill instead.WSJ • 07/15/26
3 Dividend Stocks That Are No-Brainer Buys Heading Into the Second Half of 2026The Motley Fool • 07/11/26
Novo Nordisk shares dip as latest prescription data points to GLP-1 pill slowdownProactive Investors • 07/08/26